Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia

International Journal of Cancer

Volumn 127, Issue 12, 2010, Pages 2831-2840

  Terlou, Annelinde ^a   Seters, Manon Van ^a   Kleinjan, Alex ^a   Heijmans Antonissen, Claudia ^a   Santegoets, Lindy A M ^a   Beckmann, Ilse ^a   Beurden, Marc Van ^b   Helmerhorst, Theo J M ^a   Blok, Leen J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CDKN2A; Human papilloma virus; Imiquimod; P16INK4a; Vulvar intraepithelial neoplasia

Indexed keywords

CD123 ANTIGEN; CD14 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; IMIQUIMOD; INTERLEUKIN 2 RECEPTOR ALPHA; LANGERIN; T6 ANTIGEN;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER TISSUE; CELL COUNT; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION; USUAL TYPE VULVAR INTRAEPITHELIAL NEOPLASIA; USUAL TYPE VULVAR INTRAEPTIHELIAL NEOPLASIA; VULVA CANCER; WART VIRUS;

ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTE COUNT; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 78249253334     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25302     Document Type: Article

References (41)

1. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, Haefner H, Neill S,. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005; 50: 807 -10.
2. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Munoz N, Schiffman M, Bosch FX,. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26 (Suppl 10): K17 -K28.
3. Joura EA,. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol 2002; 14: 39 -43.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518 -27.
5. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991 -8.
6. Bosch FX, de Sanjose S,. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3 -13.
7. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD,. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191: 182 -92.
8. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD,. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423 -8.
9. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169: 235 -40.
10. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G,. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995; 171: 1026 -30.
11. Santegoets LA, Seters M, Helmerhorst TJ, Heijmans-Antonissen C, Hanifi-Moghaddam P, Ewing PC, van Ijcken WF, van der Spek PJ, van der Meijden WI, Blok LJ,. HPV related VIN: highly proliferative and diminished responsiveness to extracellular signals. Int J Cancer 2007; 121: 759 -66.
12. van Seters M, van Beurden M, de Craen AJ,. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 645 -51.
13. McInturff JE, Modlin RL, Kim J,. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125: 1 -8.
14. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ,. Ins and outs of dendritic cells. Int Arch Allergy Immunol 2006; 140: 53 -72.
15. Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME, Smyth MJ, Degli-Esposti MA,. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 2005; 42: 547 -55.
16. Kaufman RH,. Intraepithelial neoplasia of the vulva. Gynecol Oncol 1995; 56: 8 -21.
17. Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D, Drouin P, Franco EL, Coutlee F,. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol 2006; 78: 814 -9.
18. Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G,. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol 2000; 96: 403 -9.
19. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, Group HIVERS,. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 2006; 107: 1023 -8.
20. Schiller M, Metze D, Luger TA, Grabbe S, Gunzer M,. Immune response modifiers-mode of action. Exp Dermatol 2006; 15: 331 -41.
21. Schon MP, Schon M,. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis 2004; 9: 291 -8.
22. Chen XZ, Mao XH, Zhu KJ, Jin N, Ye J, Cen JP, Zhou Q, Cheng H,. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Arch Dermatol Res 2010; 302: 57 -65.
23. Huang SJ, Hijnen D, Murphy GF, Kupper TS, Calarese AW, Mollet IG, Schanbacher CF, Miller DM, Schmults CD, Clark RA,. Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol 2009; 129: 2676 -85.
24. van Seters M, Fons G, van Beurden M,. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study. J Reprod Med 2002; 47: 701 -5.
25. van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Kagie MJ, Meijer CJ, Aaronson NK, Kleinjan A, Heijmans-Antonissen C, Zijlstra FJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008; 358: 1465 -73.
26. Lakshmi S, Rema P, Somanathan T,. p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus. Pathobiology 2009; 76: 141 -8.
27. O'Neill CJ, McCluggage WG,. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006; 13: 8 -15.
28. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP, Riethdorf L,. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004; 35: 1477 -83.
29. Santos M, Montagut C, Mellado B, Garcia A, Ramon y Cajal S, Cardesa A, Puig-Tintore LM, Ordi J,. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 2004; 23: 206 -14.
30. van Seters M, Beckmann I, Heijmans-Antonissen C, van Beurden M, Ewing PC, Zijlstra FJ, Helmerhorst TJ, KleinJan A,. Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia. Cancer Res 2008; 68: 6617 -22.
31. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ,. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779 -87.
32. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W,. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508 -17.
33. Leong AS,. Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl Immunohistochem Mol Morphol 2004; 12: 1 -7.
34. Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, Kitchener HC,. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res 2008; 14: 5292 -9.
35. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD, Verheijen RH, Meijer CJ,. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001; 358: 1782 -3.
36. Santos M, Landolfi S, Olivella A, Lloveras B, Klaustermeier J, Suarez H, Alos L, Puig-Tintore LM, Campo E, Ordi J,. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006; 30: 1347 -56.
37. van de Nieuwenhof HP, van Kempen LC, de Hullu JA, Bekkers RL, Bulten J, Melchers WJ, Massuger LF,. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev 2009.
38. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai XM, Stanley ER, Randolph GJ, Merad M,. Langerhans cells arise from monocytes in vivo. Nature Immunol 2006; 7: 265 -73.
39. Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, Thomson AW, Falo LD, Jr,. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2001; 2: 1151 -8.
40. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, Narni-Mancinelli E, Lauvau G,. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008; 86: 398 -408.
41. Leon B, Lopez-Bravo M, Ardavin C,. Monocyte-derived dendritic cells. Semin Immunol 2005; 17: 313 -8.